Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos Therapeutics was founded in 2016 and is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL"
Market Cap | 59.506 Million | Shares Outstanding | 105.507 Million | Avg 30-day Volume | 1.215 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.42 |
Price to Revenue | 0.0 | Debt to Equity | 0.0636 | EBITDA | -18.832 Million |
Price to Book Value | 0.4626 | Operating Margin | 0.0 | Enterprise Value | 64.793 Million |
Current Ratio | 2.355 | EPS Growth | 0.829 | Quick Ratio | 2.108 |
1 Yr BETA | 1.7408 | 52-week High/Low | 5.24 / 0.48 | Profit Margin | 0.0 |
Operating Cash Flow Growth | 22.0905 | Altman Z-Score | 5.9688 | Free Cash Flow to Firm | -20.033 Million |
Earnings Report | 2022-08-05 |
Please sign in first
66.7 Thousand total shares from 1 transactions
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
MEHRA RAJ SEE REMARKS |
|
3,281,546 | 2022-03-31 | 2 |
GOLEMBIEWSKI MICHAEL JOSEPH CHIEF FINANCIAL OFFICER |
|
78,487 | 2022-02-28 | 3 |
|
35,000 | 2022-01-05 | 3 | |
|
35,000 | 2022-01-05 | 1 | |
|
35,000 | 2022-01-05 | 1 | |
|
35,000 | 2022-01-05 | 1 | |
|
0 | 2021-01-06 | 0 | |
|
0 | 2020-01-06 | 0 | |
MORTON NEIL SVP, CHIEF BUSINESS OFFICER |
|
100,158 | 2019-01-23 | 0 |
|
13,800,000 | 2018-09-20 | 0 | |
|
No longer subject to file | 2018-08-30 | 0 | |
|
0 | 2018-03-21 | 0 | |
|
0 | 2018-01-04 | 0 | |
|
0 | 2018-01-04 | 0 | |
|
0 | 2018-01-04 | 0 | |
|
0 | 2018-01-04 | 0 | |
|
0 | 2018-01-04 | 0 | |
|
2,120,359 | 2017-08-31 | 0 | |
BOVENIZER CATHERINE VP FINANCE & CAO |
|
34,594 | 2016-05-20 | 0 |
TROUPIN BARBARA SVP, CHIEF MEDICAL OFFICER |
|
43,918 | 2016-03-15 | 0 |
|
0 | 2016-01-04 | 0 | |
|
6,524,505 | 2015-02-13 | 0 | |
MARTIN STEVEN ROBERT SENIOR VP & CFO |
|
0 | 2014-02-20 | 0 |
COX EDWARD M. VP OF BUSINESS DEVELOPMENT |
|
0 | 2014-02-20 | 0 |
|
0 | 2014-02-06 | 0 | |
BERHOLTZ RANDY E.V.P., GENERAL COUNSEL & SEC. |
|
0 | 2012-12-18 | 0 |
DAMAJ BASSAM PRESIDENT AND CEO |
|
3,222,734 | 2012-08-21 | 0 |
|
609,217 | 2012-01-03 | 0 | |
|
27,551 | 2011-01-05 | 0 | |
LIU VIVIAN H EXECUTIVE VICE PRESIDENT |
|
No longer subject to file | 2010-12-31 | 0 |
|
23,965 | 2010-06-30 | 0 | |
WESTGATE MARK VICE PRESIDENT & CFO |
|
879,318 | 2010-04-09 | 0 |
|
191,290 | 2009-10-06 | 0 | |
|
323,579 | 2009-10-06 | 0 | |
|
267,948 | 2009-10-06 | 0 | |
|
0 | 2009-08-27 | 0 | |
|
5,714,630 | 2009-07-07 | 0 | |
SOUTHPOINT CAPITAL ADVISORS LP |
|
7,927,952 | 2008-05-12 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-03-31 16:34:22 -0400 | 2022-03-31 | P | 66,667 | $0.85 | a | 3,281,546 | direct | 5.2332 | -4.8919 | 5.2332 | 2 | -4.8919 | 6 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
SEELOS THERAPEUTICS INC SEEL | 2022-05-16 16:15:03 UTC | -0.1562 | 0.9762 | 1600000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-16 15:45:03 UTC | -0.1562 | 0.9762 | 1600000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-16 15:15:03 UTC | -0.1562 | 0.9762 | 1600000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-16 14:45:03 UTC | -0.18 | 1.0 | 1600000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-16 14:15:03 UTC | -0.18 | 1.0 | 1600000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-16 13:45:04 UTC | -0.18 | 1.0 | 1600000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-16 13:15:03 UTC | -0.18 | 1.0 | 1500000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-16 12:45:04 UTC | -0.18 | 1.0 | 1500000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 22:15:03 UTC | -0.18 | 1.0 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 21:45:03 UTC | -0.1737 | 0.9937 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 21:15:03 UTC | -0.1737 | 0.9937 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 20:45:03 UTC | -0.208 | 1.028 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 20:15:03 UTC | -0.208 | 1.028 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 19:45:04 UTC | -0.208 | 1.028 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 19:15:03 UTC | -0.208 | 1.028 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 18:45:03 UTC | -0.2006 | 1.0206 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 18:15:03 UTC | -0.2006 | 1.0206 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 17:45:03 UTC | -0.2006 | 1.0206 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 17:15:03 UTC | -0.2006 | 1.0206 | 800000 |
SEELOS THERAPEUTICS INC SEEL | 2022-05-13 16:45:03 UTC | -0.1734 | 0.9934 | 800000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|